Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04683471 · ClinicalTrials.gov registry record · NA

Pilot Trial of a System for Motor Function Recovery

A NA study of Spinal Cord Diseases, sponsored by Niche Biomedical, Inc. dba ANEUVO.

Completed
Registry status
NA
Development phase
12
Enrollment target
3
Study locations

NCT04683471 is a NA study of Spinal Cord Diseases that has completed, run by Niche Biomedical, Inc. dba ANEUVO. The registered enrollment target is 12 participants, below the 23-participant average among 9 other Spinal Cord Diseases trials with a reported enrollment target (48% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04683471, a NA study of Spinal Cord Diseases, has completed, sponsored by Niche Biomedical, Inc. dba ANEUVO.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
3
Study locations

Study Summary

This is a multi-center, prospective, blinded, pilot feasibility study to evaluate improvement in sensory and motor function with sham.

Conditions Studied

Interventions

  • DEVICE Sham
  • DEVICE Stimulator

Study Locations (3)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Maryland

  • Kennedy Krieger Institute - Baltimore

Texas

  • Houston Methodist Research Institute - Houston

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2020-11-30
Est. Completion 2022-03-22
Phase NA

What the Registry Record Tells You About NCT04683471

The ClinicalTrials.gov registry entry for NCT04683471 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 23-participant average among 9 other Spinal Cord Diseases trials with a reported enrollment target (48% lower). The listed sponsor is Niche Biomedical, Inc. dba ANEUVO, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Cord Diseases appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.

NCT04683471 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Maryland, Texas.

Frequently Asked Questions

What is clinical trial NCT04683471 about?

NCT04683471 is a clinical study titled "Pilot Trial of a System for Motor Function Recovery". This is a multi-center, prospective, blinded, pilot feasibility study to evaluate improvement in sensory and motor function with sham.

What is the current status of trial NCT04683471?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2020-11-30. Estimated completion is 2022-03-22.

What conditions does trial NCT04683471 study?

This clinical trial studies the following conditions: Spinal Cord Diseases.

What interventions are being tested in trial NCT04683471?

The interventions under investigation include: Sham (DEVICE), Stimulator (DEVICE).

Who is sponsoring clinical trial NCT04683471?

This trial is sponsored by Niche Biomedical, Inc. dba ANEUVO, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04683471 being conducted?

This trial has 3 study locations across Illinois, Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.